New CFO Appointment
New CFO Appointment
The appointment of John Smither as Chief Financial Officer has also been announced, with Mr. Smither continuing to lead the Company’s finance organization and support operational and strategic priorities. The leadership changes are effective immediately, and additional information will be disclosed in a Current Report on Form 8‑K filed with the U.S. Securities and Exchange Commission.
14/07/2026 | MBX Biosciences, Inc.